Skip to content

Colgate-Palmolive CL Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Clorox logo
CloroxCLX
Hain Celestial Group logo
Hain Celestial GroupHAIN
Kenvue logo
KenvueKVUE
Perrigo Company logo
Perrigo CompanyPRGO
Helen Of Troy logo
Helen Of TroyHELE
The Honest Company logo
The Honest CompanyHNST

Other financials

Income statement

See full
Revenue$5.3B+8.4%
Gross profit$3.2B+8.0%
Operating income$964.0M-10.4%
Net income$646.0M-6.4%
EPS (diluted)$0.80-5.9%

Balance sheet

See full
Cash & equivalents$1.3B+20.1%
Total debt$8.0B-3.6%
Total equity$145.0M-60.1%
Total assets$16.6B-0.2%

Cash flow

See full
Operating cash flow$747.0M+24.5%
CapEx$138.0M+11.3%
Free cash flow$609.0M+27.9%

Valuation

See full
Market cap$73.36B+7.0%
Enterprise value$80B+5.2%
P/E34.5×+11.0×
P/S3.5×+0.1×

Profitability

See full
Gross margin60.1%-0.6pp
Operating margin15.4%-6.2pp
Net margin10.2%-4.3pp
FCF margin18.1%+0.7pp

Returns & leverage

See full
Return on equity836.2%-141pp
Debt / equity55×+32.2×
Current ratio+0.2×

Where this comes from

Reported directly by Colgate-Palmolive in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Colgate-Palmolive’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Colgate-Palmolive's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Colgate-Palmolive's common stock, shares authorized (in shares)?
Colgate-Palmolive (CL) reported common stock, shares authorized (in shares) of 2B in Q1 2026.
How has Colgate-Palmolive's common stock, shares authorized (in shares) changed year-over-year?
Colgate-Palmolive's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from 2B to 2B.
What is the long-term trend for Colgate-Palmolive's common stock, shares authorized (in shares)?
Over 4 years (2021 to 2025), Colgate-Palmolive's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from 2B to 2B.